Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "Hantzsch-type" dihydropyridine hypotensive agents. 3.

× No keyword cloud information.

23 in total

1. Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.

Authors: D A Langs; Y W Kwon; P D Strong; D J Triggle
Journal: J Comput Aided Mol Des Date: 1991-04 Impact factor: 3.686

2. Calcium channel antagonists: pharmacological considerations.

Authors: D Rampe; C M Su; F Yousif; D J Triggle
Journal: Br J Clin Pharmacol Date: 1985 Impact factor: 4.335

3. Structure-activity studies on nifedipine in isolated cardiac muscle.

Authors: R Rodenkirchen; R Bayer; R Steiner; F Bossert; H Meyer; E Möller
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1979-12 Impact factor: 3.000

4. Intercepted-Knoevenagel condensation for the synthesis of unsymmetrical fused-tricyclic 4H-pyrans.

Authors: Charles Shearer; Oriane Desaunay; Stephen Zorc; Alexis D Richaud; Shyam S Samanta; Nagalakshmi Jeedimalla; Stéphane P Roche
Journal: Tetrahedron Date: 2019-09-17 Impact factor: 2.457

5. Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.

Authors: Christiaan Jardínez; Alberto Vela; Julián Cruz-Borbolla; Rodrigo J Alvarez-Mendez; José G Alvarado-Rodríguez
Journal: J Mol Model Date: 2016-11-26 Impact factor: 1.810

10. Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors: M Spedding
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1982-02 Impact factor: 3.000

"Hantzsch-type" dihydropyridine hypotensive agents. 3.

1. Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.

2. Calcium channel antagonists: pharmacological considerations.

3. Structure-activity studies on nifedipine in isolated cardiac muscle.

4. Intercepted-Knoevenagel condensation for the synthesis of unsymmetrical fused-tricyclic 4H-pyrans.

5. Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.

6. RWJ-22108--a novel airway tissue--selective calcium channel blocker.

7. Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.

8. Expedient Access to 2,3-Dihydropyridines from Unsaturated Oximes by Rh(III)-Catalyzed C-H Activation.

9. Novel halogenated dihydropyridine derivatives with high vascular selectivity.

10. Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.